CypD-IN-29 is an inhibitor of cyclophilin D (CypD), a mitochondrial-specific cyclophilin that binds to amyloid-beta in brain mitochondria and promotes the formation of the mitochondrial permeability transition pore (mPTP); it is targeted for the treatment of Alzheimer's disease (KD = 88.2 nM).